FGF9 monomer-dimer equilibrium regulates extracellular matrix affinity and tissue diffusion

Nature Genetics

Volumn 41, Issue 3, 2009, Pages 289-298

  Harada, Masayo ^a,b   Murakami, Hirotaka ^b   Okawa, Akihiko ^b   Okimoto, Noriaki ^c   Hiraoka, Shuichi ^a,h   Nakahara, Taka ^d,i   Akasaka, Ryogo ^c   Shiraishi, Yo Ichi ^e   Futatsugi, Noriyuki ^c   Mizutani Koseki, Yoko ^a   Kuroiwa, Atsushi ^e   Shirouzu, Mikako ^c   Yokoyama, Shigeyuki ^c,f   Taiji, Makoto ^c   Iseki, Sachiko ^d   Ornitz, David M ^g   Koseki, Haruhiko ^a  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c RIKEN   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e NAGOYA UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

ⁱ NIPPON DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; FIBROBLAST GROWTH FACTOR; HEPARIN; MONOMER; PROTEOHEPARAN SULFATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CHONDROGENESIS; CRANIOFACIAL SYNOSTOSIS; DIMERIZATION; ELBOW; EXTRACELLULAR MATRIX; GENE CONTROL; GENE MAPPING; GENE OVEREXPRESSION; GENOTYPE; HISTOPATHOLOGY; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; KNEE; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; MOLECULAR MECHANICS; MOUSE; MOUSE MUTANT; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; SYNOSTOSIS; ULTRACENTRIFUGATION;

ANIMALS; BASE SEQUENCE; DIFFUSION; DNA MUTATIONAL ANALYSIS; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTOR 9; HEPARAN SULFATE PROTEOGLYCANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTRATE SPECIFICITY; SYNOSTOSIS; TISSUE DISTRIBUTION;

MUS;

EID: 61349091627     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.316     Document Type: Article

References (43)

1. Ornitz, D.M. & Itoh, N. Fibroblast growth factors. Genome Biol. 2, reviews 3005 (2001).
2. Wilkie, A.O.M. Bad bone, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev. 16, 187-203 (2005).
3. Su, N., Du, X. & Chen, L. FGF signaling: its role in bone development and human skeleton diseases. Front. Biosci. 13, 2842-2865 (2008).
4. Ornitz, D.M. & Marie, P.J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16, 1446-1465 (2002).
5. Martin, G.R. The roles of FGFs in the early development of vertebrate limbs. Genes Dev. 12, 1571-1586 (1998).
6. Ornitz, D.M. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev. 16, 205-213 (2005).
7. Montero, A. et al. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J. Clin. Invest. 105, 1085-1093 (2000).
8. Hung, I.H., Yu, K., Lavine, K.J. & Ornitz, D.M. FGF9 regulates early hypertrophic chondrocyte differentiation and skeketal vascularization in the developing stylopod. Dev. Biol. 307, 300-313 (2007).
9. Liu, Z., Xu, J., Colvin, J.S. & Ornitz, D.M. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev. 16, 859-869 (2002).
10. Ohbayashi, N. et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 16, 870-879 (2002).
11. Garofalo, S. et al. Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice. J. Bone Miner. Res. 14, 1909-1915 (1999).
12. Ornitz, D.M. FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays 22, 108-112 (2000).
13. Nybakken, K. & Perrimon, N. Heparan sulfate proteoglycan modulation of developmental signaling in Drosophila. Biochim. Biophys. Acta 1573, 280-291 (2002).
14. Plotnikov, A.N. et al. Crystal structure of fibroblast growth factor 9 reveals regions implicated in dimerization and autoinhibition. J. Biol. Chem. 276, 4322-4329 (2001).
15. Hecht, H.J. et al. Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfaces. Acta Crystallogr. D Biol. Crystallogr. 57, 378-384 (2001).
16. Murakami, H. et al. Elbow knee synostosis (Eks): a new mutation on mouse Chromosome 14. Mamm. Genome 13, 341-344 (2002).
17. Ornitz, D.M. et al. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271, 15292-15297 (1996).
18. Hajihosseini, M.K. & Heath, J.K. Expression patterns of fibroblast growth factors-18 and -20 in mouse embryos is suggestive of novel roles in calvarial and limb development. Mech. Dev. 113, 79-83 (2002).
19. Colvin, J.S., Feldman, B., Nadeau, J.H., Goldfarb, M. & Ornitz, D.M. Genomic organization and embryonic expression of the mouse fibroblast growth factor 9 gene. Dev. Dyn. 216, 72-88 (1999).
20. Wang, Q., Green, R.P., Zhao, G. & Ornitz, D.M. Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains. Development 128, 3867-3876 (2001).
21. Eswarakumar, V.P., Horowitz, M.C., Locklin, R., Morriss-Kay, G.M. & Lonai, P. A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc. Natl. Acad. Sci. USA 101, 12555-12560 (2004).
22. Storm, E.E. & Kingsley, D.M. Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 122, 3969-3979 (1996).
23. Nalin, A.M., Greenlee, T.K. & Sandell, L.J. Collagen gene expression during development of avian synovial joints: Transient expression of types II and XI collagen genes in the joint capsule. Dev. Dyn. 203, 352-362 (1995).
24. Iseki, S. et al. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development 124, 3375-3384 (1997).
25. Yoshida, T. et al. Twist is required for establishment of the mouse coronal suture. J. Anat. 206, 437-444 (2005).
26. Flaumenhaft, R., Moscatelli, D. & Rifkin, D.B. Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J. Cell Biol. 111, 1651-1659 (1990).
27. Woo, H.J. & Roux, B. Calculation of absolute protein-ligand binding free energy from computer simulations. Proc. Natl. Acad. Sci. USA 102, 6825-6830 (2005).
28. Schlessinger, J. et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 6, 743-750 (2000).
29. Dowd, C.J., Cooney, C.L. & Nugent, M.A. Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding. J. Biol. Chem. 274, 5236-5244 (1999).
30. Johnson, D., Iseki, S., Wilkie, A.O.M. & Morriss-Kay, G.M. Expression patterns of Twist and Fgfr1, -2 and -3 in the developing mouse coronal suture suggest a key role for Twist in suture initiation and biogenesis. Mech. Dev. 91, 341-345 (2000).
31. Tsang, M. & Dawid, I.B. Promotion and attenuation of FGF signaling through the Ras-MAPK pathway. Sci. STKE 2004, pe17 (2004).
32. Mohammadi, M., Olsen, S.K. & Ibrahimi, O.A. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 16, 107-137 (2005).
33. Ornitz, D.M. et al. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12, 240-247 (1992).
34. Venkataraman, G., Shriver, Z., Davis, J.C. & Sasisekharan, R. Fibroblast growth factors 1 and 2 are distinct in oligomerization in the presence of heparin-like glycosaminoglycans. Proc. Natl. Acad. Sci. USA 96, 1892-1897 (1999).
35. Kessel, M. & Gruss, P. Murine developmental control genes. Science 249, 374-379 (1990).
36. Kessel, M. & Gruss, P. Homeotic transformations of murine vertebrae and concomitant alteration of Hox codes induced by retinoic acid. Cell 67, 89-104 (1991).
37. Verdonk, M.L., Cole, J.C., Hartshorn, M.J., Murray, C.W. & Taylor, R.D. Improved protein-ligand docking using GOLD. Proteins 52, 609-623 (2003).
38. Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W. & Klein, M.L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926-935 (1983).
39. Case, D.A. et al. AMBER 8 (University of California, San Francisco, 2004).
40. Narumi, T. et al. A 55 Tflops simulation of amyloid-forming peptides from yeast prion Sup35 with the special-purpose computer System MD-GRAPE3. 〈http://doi.acm.org/10.1145/1188455.1188506〉 (2006).
41. Duan, Y. et al. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 24, 1999-2012 (2003).
42. Srinivasan, J., Miller, J., Kollma, P.A. & Case, D.A. Continuum solvent studies of the stability of RNA hairpin loops and helices. J. Biomol. Struct. Dyn. 16, 671-682 (1998).
43. Hughes, S.H., Greenhouse, J.J., Petropoulos, C.J. & Sutrave, P. Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J. Virol. 61, 3004-3012 (1987).